Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 FY- Text added to 2021 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
abatement, absolute, Acelink, adipose, adiposity, ADME, ALX, ambulatory, Amgen, Anand, Andrea, Ann, argued, asymptomatic, bachelor, ballooning, Barbara, bariatric, Baxter, Bhaskar, Bio, Black, broken, buildout, Camer, carcinogenicity, catch, Centrexion, Chemist, cholesterol, Christy, CI, circumference, Clin, CMC, conceptual, Conceptually, congestive, content, Cou, covariance, CRL, customarily, cut, cycle, DBP, dermatology, diarrhea, disincentivizing, dismissed, DPN, ECG, echocardiogram, Eliem, Elismetrep, Engeli, Fall, Fatima, fed, fellowship, FFS, FIONA, footprint, gabapentinoid, GGT, glycemic, gradual, GRC, Green, Haisco, Harmony, HDL, headquarter, hepatic, hepatocellular, HHS, hypertrophy, hypothesize, ID, illegitimate, immunology, implantable, infarction, infestation, infiltration, Instil, insulin, IntellisTM, interval, IO, Jersey, Jinnah, JOTROL, Karyopharm, Kerendia, kg, Khan, Labour, LDL, leave, Leicester, Li, lipoprotein, liraglutide, Loewen, LOQ, Loughborough, LS, margin, Medtronic, metabolite, MetroBiotech, MHLW, Ministry, Miyashita, mobilization, modest, monetization, mother, mouse, mRNA, myocardial, NaN, Neurol, Nevro, nonalcoholic, noncurrent, occupancy, Oliger, Omicron, oncology, oropharyngeal, overexpression, PDUFA, Pepperdine, Plasma, plotted, presence, processor, prohormone, proteinuria, proteinuric, Pure, QT, Quark, quick, reclassed, regular, reinstate, relaxed, Replimune, residency, Ruff, Saha, Samina, Santa, Sarepta, SBP, Schlueter, SD, Senza, sex, Shamim, Shin, Shire, shortly, Sichuan, Sierra, skeletal, skeptical, slightly, Spring, step, stimulation, Stoke, Subpart, surgery, symptomatic, Tarlige, TEAE, tenant, tenure, timepoint, Toeplitz, transferase, Transl, triglyceride, UK, ULN, uncommon, unredacted, unstructured, Uruno, VantaTM, variant, visceral, waist, Welfare, white, yearly, Zhang, Zhejiang
Removed:
AB, ablation, advancing, albumin, allosteric, analyzed, atacicept, Aurigene, BEAM, begun, biologic, Bioscience, Boston, BV, central, CEO, clarification, clearance, cohort, comparative, compelling, Complexa, complication, comprise, concentrated, creatinine, diastolic, differentiation, Dimerix, distance, dosed, earliest, ease, Eighteen, Elaine, employed, enlarged, Escalier, evidenced, gap, GenKyoTex, Genzyme, glomeruli, gold, hearing, histologic, hub, immunosuppressant, inhibitor, inulin, journal, kgaa, link, logistic, meaningfully, Merck, mmHg, moved, nefecon, negotiated, nephron, nephrotoxic, nurse, outpatient, overestimate, Pfizer, pharmacy, potently, powered, prepaid, proliferation, recurring, repeal, retrospective, Retrotope, room, RORgT, SA, shelf, sizing, strong, subgroup, susceptible, systolic, temperature, thickening, thin, transition, underestimate, utilization, venglustat, walk
Valuein 2020 FY filing- Value in 2021 FY filing
Original filings
Filing view